We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Allergan Seeks To Pause Antitrust Suits Pending MDL Call

Law360, New York (December 21, 2017, 3:41 PM EST) -- Allergan Inc. asked a Texas federal judge on Thursday to pause several suits alleging the company delayed the launch of generic versions of its dry-eye medication Restasis, in part by transferring patents to a Native American tribe, until a decision is made about forming a multidistrict litigation.

Allergan urged the joint panel on multidistrict litigation earlier this month to consolidate four Eastern District of Texas cases with four others filed in the Eastern District of New York, all alleging antitrust violations by the drugmaker. The company...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.